Effect of knocking down miR-19a on proliferation and apoptosis of human glioma cell line U251 in vitro
Ruibing Du
Abstract
Ruibing Du
Abstract
Objective To investigate the effect of knocking down miR -19a on proliferation and apoptosis of human glioma cell line U251 in vitro. Methods U251 cells were cultured routinely. MiR-19a inhibitor was transfected into U251 cells by Lipofectamine 2000. At the same time, the negative control group and blank control group were established. The expression level of miR-19a was detected by RT-PCR. and cell proliferation was analyzed by CCK-8 assay. The changes of cell apoptosis and cycle were monitored by flow cytometry. Results Compared with the negative control group and blank control group, qRT-PCR showed that the expression level of miR-19a was significantly reduced after transfection (F = 124.72, P < 0.01). CCK-8 revealed that proliferation ability of miR-19a inhibitor group was significantly suppressed. The cell survival rate in miR-19a inhibitor group after 48 h was (48.27±8.23) %, compared with the blank control group(100.00 %), the difference was statistically significant (t = 12.45, P < 0.01). After low-expression of miR-19a, the G0/G1 phase cells were increased and S phase cells were decreased. The low-expression of miR-19a could induce cell apoptosis. Conclusions Low-expression of miR-19a can inhibit cell proliferation, block G1/S transition and induce apoptosis in human glioma cell line U251. miR-19a may serve as an attractive target of gene therapy for glioblastoma. Key words: miR-19a; Human glioma; Cell proliferation; Apoptosis
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of knocking down miR -19a on proliferation and apoptosis of human glioma cell line U251 in vitro. Methods U251 cells were cultured routinely. MiR-19a inhibitor was transfected into U251 cells by Lipofectamine 2000. At the same time, the negative control group and blank control group were established. The expression level of miR-19a was detected by RT-PCR. and cell proliferation was analyzed by CCK-8 assay. The changes of cell apoptosis and cycle were monitored by flow cytometry. Results Compared with the negative control group and blank control group, qRT-PCR showed that the expression level of miR-19a was significantly reduced after transfection (F = 124.72, P < 0.01). CCK-8 revealed that proliferation ability of miR-19a inhibitor group was significantly suppressed. The cell survival rate in miR-19a inhibitor group after 48 h was (48.27±8.23) %, compared with the blank control group(100.00 %), the difference was statistically significant (t = 12.45, P < 0.01). After low-expression of miR-19a, the G0/G1 phase cells were increased and S phase cells were decreased. The low-expression of miR-19a could induce cell apoptosis. Conclusions Low-expression of miR-19a can inhibit cell proliferation, block G1/S transition and induce apoptosis in human glioma cell line U251. miR-19a may serve as an attractive target of gene therapy for glioblastoma. Key words: miR-19a; Human glioma; Cell proliferation; Apoptosis
Key concepts: Apoptosis, Lipofectamine, Transfection, Cell growth, Glioma, Cell cycle, Flow cytometry, Cell culture